Paper34722189
Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review.
Muhammad H and 9 others. J Clin Transl Hepatol, 2021. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review. Papers, record 34722189. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34722189
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| K08 CA237624 | NCI NIH HHS | United States | K08CA237624 | PubMed |
Source NIH RePORTER
References113
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29551707 | Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study. | J Hepatol | 2018 | https://conductscience.org/library/papers/29551707 | PubMed |
| 2 | 31302190 | Immune checkpoint inhibitor therapy in solid organ transplant recipients: A patient-centered systematic review. | J Am Acad Dermatol | 2020 | https://conductscience.org/library/papers/31302190 | PubMed |
| 3 | 24002285 | Thirty-year outcomes of the national hepatitis B immunization program in Taiwan. | JAMA | 2013 | https://conductscience.org/library/papers/24002285 | PubMed |
| 4 | 26130250 | Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence. | Ann Gastroenterol | 2015 | https://conductscience.org/library/papers/26130250 | PubMed |
| 5 | 18650514 | Sorafenib in advanced hepatocellular carcinoma. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18650514 | PubMed |
| 6 | 30705718 | Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation. | World J Hepatol | 2019 | https://conductscience.org/library/papers/30705718 | PubMed |
| 7 | 30878469 | AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review. | Gastroenterology | 2019 | https://conductscience.org/library/papers/30878469 | PubMed |
| 8 | 32908865 | Increased Surgical Complications but Improved Overall Survival with Adult Living Donor Compared to Deceased Donor Liver Transplantation: A Systematic Review and Meta-Analysis. | Biomed Res Int | 2020 | https://conductscience.org/library/papers/32908865 | PubMed |
| 9 | 17717454 | Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. | Ann Surg | 2007 | https://conductscience.org/library/papers/17717454 | PubMed |
| 10 | 22882750 | Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. | Am J Transplant | 2012 | https://conductscience.org/library/papers/22882750 | PubMed |
| 11 | 16527702 | The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. | Clin Gastroenterol Hepatol | 2006 | https://conductscience.org/library/papers/16527702 | PubMed |
| 12 | 30548884 | Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes. | Hepatology | 2019 | https://conductscience.org/library/papers/30548884 | PubMed |
| 13 | 28682909 | Statins intake and risk of liver cancer: A dose-response meta analysis of prospective cohort studies. | Medicine (Baltimore) | 2017 | https://conductscience.org/library/papers/28682909 | PubMed |
| 14 | 11391528 | Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. | Hepatology | 2001 | https://conductscience.org/library/papers/11391528 | PubMed |
| 15 | 19095497 | Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. | Lancet Oncol | 2009 | https://conductscience.org/library/papers/19095497 | PubMed |
| 16 | 30967904 | Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation. | World J Hepatol | 2019 | https://conductscience.org/library/papers/30967904 | PubMed |
| 17 | 29205416 | The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study. | Hepatology | 2018 | https://conductscience.org/library/papers/29205416 | PubMed |
| 18 | 23837134 | Important predictor of mortality in patients with end-stage liver disease. | Clin Mol Hepatol | 2013 | https://conductscience.org/library/papers/23837134 | PubMed |
| 19 | 2535924 | The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. | Ann Surg | 1989 | https://conductscience.org/library/papers/2535924 | PubMed |
| 20 | 29107679 | Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. | Lancet Oncol | 2017 | https://conductscience.org/library/papers/29107679 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41357375 | Association of vascular invasion and tumor differentiation on post-liver transplant outcomes in patients with hepatocellular carcinoma. | World J Transplant | 2025 | https://conductscience.org/library/papers/41357375 | PubMed |
| 40962495 | From comics to care: exploring the education potential of graphic novel in organ transplantation journey. | Med Humanit | 2026 | https://conductscience.org/library/papers/40962495 | PubMed |
| 40191726 | COPB2 promotes hepatocellular carcinoma progression through regulation of YAP1 nuclear translocation. | Oncol Res | 2025 | https://conductscience.org/library/papers/40191726 | PubMed |
| 39797227 | Are Ki-67 and Procalcitonin Expression Levels Useful in Predicting the Biological Behavior of Hepatocellular Carcinoma After Liver Transplantation? | J Clin Med | 2024 | https://conductscience.org/library/papers/39797227 | PubMed |
| 39172301 | Hepatic Resection as the Primary Treatment Method for Hepatocellular Carcinoma After Orthotopic Liver Transplantation. | Ann Surg Oncol | 2024 | https://conductscience.org/library/papers/39172301 | PubMed |
| 38576752 | Liver transplantation for hepatocellular carcinoma in India: Are we ready for 2040? | World J Transplant | 2024 | https://conductscience.org/library/papers/38576752 | PubMed |
| 38098611 | Role of the immune system in liver transplantation and its implications for therapeutic interventions. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/38098611 | PubMed |
| 37917059 | Racial Disparities in Candidates for Hepatocellular Carcinoma Liver Transplant After 6-Month Wait Policy Change. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/37917059 | PubMed |
| 37719959 | Fucoidan Ameliorates Ferroptosis in Ischemia-reperfusion-induced Liver Injury through Nrf2/HO-1/GPX4 Activation. | J Clin Transl Hepatol | 2023 | https://conductscience.org/library/papers/37719959 | PubMed |
| 37685524 | Risk of Recurrence of Hepatocarcinoma after Liver Transplantation: Performance of Recurrence Predictive Models in a Cohort of Transplant Patients. | J Clin Med | 2023 | https://conductscience.org/library/papers/37685524 | PubMed |
| 37296912 | Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37296912 | PubMed |
| 36891706 | [Research progress and clinical application value of exosomal circRNAs in hepatocellular carcinoma]. | Zhonghua Gan Zang Bing Za Zhi | 2022 | https://conductscience.org/library/papers/36891706 | PubMed |
| 36811666 | Efficient chemosensitizing and antimetastatic combinations of a naturally occurring trans-ferulic acid with different chemotherapies on an in vitro hepatocellular carcinoma model. | Naunyn Schmiedebergs Arch Pharmacol | 2023 | https://conductscience.org/library/papers/36811666 | PubMed |
| 36727232 | [MicroRNA 424-5p promotes the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting Kinesin family member 23]. | Zhonghua Gan Zang Bing Za Zhi | 2022 | https://conductscience.org/library/papers/36727232 | PubMed |
| 36437845 | Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation. | World J Transplant | 2022 | https://conductscience.org/library/papers/36437845 | PubMed |
| 36291898 | Hepatocellular Carcinoma Recurrence and Mortality Rate Post Liver Transplantation: Meta-Analysis and Systematic Review of Real-World Evidence. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36291898 | PubMed |
| 36268362 | Successful use of venous graft from native liver with hepatocellular carcinoma during living donor liver transplantation with no impact on recurrence rate: A retrospective cohort study. | Ann Med Surg (Lond) | 2022 | https://conductscience.org/library/papers/36268362 | PubMed |
| 36072797 | Progress in gallbladder cancer with lymph node metastasis. | Front Oncol | 2022 | https://conductscience.org/library/papers/36072797 | PubMed |
| 35936699 | The Combination of AFP and "Up-To-Seven" Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients. | Front Oncol | 2022 | https://conductscience.org/library/papers/35936699 | PubMed |
| 35444459 | HSPB11 is a Prognostic Biomarker Associated with Immune Infiltrates in Hepatocellular Carcinoma. | Int J Gen Med | 2022 | https://conductscience.org/library/papers/35444459 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE | 1636 | PubTator's text mining | https://conductscience.org/library/genes/1636 | NCBI Gene |
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 | NCBI Gene |
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| FLT3 | 2322 | PubTator's text mining | https://conductscience.org/library/genes/2322 | NCBI Gene |
| KIT | 3815 | PubTator's text mining | https://conductscience.org/library/genes/3815 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| PDGFRB | 5159 | PubTator's text mining | https://conductscience.org/library/genes/5159 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
| TXK | 7294 | PubTator's text mining | https://conductscience.org/library/genes/7294 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34722189
GET https://conductscience.org/api/papers/v1/34722189/references?page=2